Search research articles
Contact Us
Filters
Showing results (11-20 of 366) with videos related to
Page
of 37
Sort By:
The Lancet. Oncology
|
December 16, 2014
IBIS-I tamoxifen update: maturity brings questions
Rowan T Chlebowski
Journal of the National Cancer Institute
|
December 19, 2009
Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy
Rowan T Chlebowski
The Lancet. Oncology
|
June 21, 2015
Interpreting quality-of-life data from the SOFT and TEXT trials
Rowan T Chlebowski
Clinical Breast Cancer
|
April 6, 2005
Bone health in women with early-stage breast cancer
Rowan T Chlebowski
JAMA
|
August 10, 2006
Aromatase inhibitors and breast cancer treatment
Rowan T Chlebowski
Breast (Edinburgh, Scotland)
|
March 28, 2008
Translating trial data into patients benefits: making the right choice
Rowan T Chlebowski
Annual Review of Medicine
|
January 31, 2002
Breast cancer risk reduction: strategies for women at increased risk
Rowan T Chlebowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2010
Lifestyle and breast cancer risk: the way forward?
Rowan T Chlebowski
Breast Cancer Research and Treatment
|
December 23, 2008
Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer
Rowan T Chlebowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Aromatase inhibitor-associated arthralgias
Rowan T Chlebowski
Page
of 37
Search research articles
Search
Showing results (11-20 of 366) with videos related to
Sort By:
Page
of 37
The Lancet. Oncology
|
December 16, 2014
IBIS-I tamoxifen update: maturity brings questions
Rowan T Chlebowski
Journal of the National Cancer Institute
|
December 19, 2009
Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy
Rowan T Chlebowski
The Lancet. Oncology
|
June 21, 2015
Interpreting quality-of-life data from the SOFT and TEXT trials
Rowan T Chlebowski
Clinical Breast Cancer
|
April 6, 2005
Bone health in women with early-stage breast cancer
Rowan T Chlebowski
JAMA
|
August 10, 2006
Aromatase inhibitors and breast cancer treatment
Rowan T Chlebowski
Breast (Edinburgh, Scotland)
|
March 28, 2008
Translating trial data into patients benefits: making the right choice
Rowan T Chlebowski
Annual Review of Medicine
|
January 31, 2002
Breast cancer risk reduction: strategies for women at increased risk
Rowan T Chlebowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2010
Lifestyle and breast cancer risk: the way forward?
Rowan T Chlebowski
Breast Cancer Research and Treatment
|
December 23, 2008
Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer
Rowan T Chlebowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Aromatase inhibitor-associated arthralgias
Rowan T Chlebowski
Page
of 37